PNT Annual EBIT
$125.52 M
+$171.11 M+375.36%
31 December 2022
Summary:
As of February 5, 2025, PNT annual earnings before interest & taxes is $125.52 million, with the most recent change of +$171.11 million (+375.36%) on December 31, 2022. During the last 3 years, it has risen by +$138.80 million (+1045.21%).PNT EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PNT Quarterly EBIT
-$29.63 M
+$1.87 M+5.95%
30 September 2023
Summary:
As of February 5, 2025, PNT quarterly earnings before interest & taxes is -$29.63 million, with the most recent change of +$1.87 million (+5.95%) on September 30, 2023. Over the past year, it has dropped by -$4.99 million (-20.25%).PNT Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PNT TTM EBIT
$107.77 M
-$4.99 M-4.42%
30 September 2023
Summary:
As of February 5, 2025, PNT TTM earnings before interest & taxes is $107.77 million, with the most recent change of -$4.99 million (-4.42%) on September 30, 2023. Over the past year, it has increased by +$187.78 million (+234.70%).PNT TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PNT EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +375.4% | -20.3% | +234.7% |
| 3 y3 years | +1045.2% | -873.0% | +1844.4% |
| 5 y5 years | +1045.2% | -845.4% | +3539.2% |
PNT EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -1.1% | -115.5% | -14.1% |
POINT Biopharma Global EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$29.63 M(-5.9%) | $107.77 M(-4.4%) |
| June 2023 | - | -$31.50 M(+40.2%) | $112.76 M(-5.5%) |
| Mar 2023 | - | -$22.46 M(-111.7%) | $119.37 M(-4.9%) |
| Dec 2022 | $125.52 M(-375.4%) | $191.36 M(-876.7%) | $125.52 M(-256.9%) |
| Sept 2022 | - | -$24.64 M(-1.0%) | -$80.01 M(+10.5%) |
| June 2022 | - | -$24.89 M(+52.6%) | -$72.40 M(+28.9%) |
| Mar 2022 | - | -$16.31 M(+15.1%) | -$56.19 M(+23.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$45.59 M(+243.3%) | -$14.17 M(-16.8%) | -$45.62 M(+23.3%) |
| Sept 2021 | - | -$17.03 M(+96.3%) | -$36.98 M(+60.8%) |
| June 2021 | - | -$8.68 M(+51.2%) | -$23.00 M(+31.8%) |
| Mar 2021 | - | -$5.74 M(+3.7%) | -$17.45 M(+49.0%) |
| Dec 2020 | -$13.28 M | -$5.53 M(+81.7%) | -$11.71 M(+89.6%) |
| Sept 2020 | - | -$3.04 M(-2.8%) | -$6.18 M(+97.2%) |
| June 2020 | - | -$3.13 M | -$3.13 M |
FAQ
- What is POINT Biopharma Global annual earnings before interest & taxes?
- What is the all time high annual EBIT for POINT Biopharma Global?
- What is POINT Biopharma Global annual EBIT year-on-year change?
- What is POINT Biopharma Global quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for POINT Biopharma Global?
- What is POINT Biopharma Global quarterly EBIT year-on-year change?
- What is POINT Biopharma Global TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for POINT Biopharma Global?
- What is POINT Biopharma Global TTM EBIT year-on-year change?
What is POINT Biopharma Global annual earnings before interest & taxes?
The current annual EBIT of PNT is $125.52 M
What is the all time high annual EBIT for POINT Biopharma Global?
POINT Biopharma Global all-time high annual earnings before interest & taxes is $126.92 M
What is POINT Biopharma Global annual EBIT year-on-year change?
Over the past year, PNT annual earnings before interest & taxes has changed by +$171.11 M (+375.36%)
What is POINT Biopharma Global quarterly earnings before interest & taxes?
The current quarterly EBIT of PNT is -$29.63 M
What is the all time high quarterly EBIT for POINT Biopharma Global?
POINT Biopharma Global all-time high quarterly earnings before interest & taxes is $191.36 M
What is POINT Biopharma Global quarterly EBIT year-on-year change?
Over the past year, PNT quarterly earnings before interest & taxes has changed by -$4.99 M (-20.25%)
What is POINT Biopharma Global TTM earnings before interest & taxes?
The current TTM EBIT of PNT is $107.77 M
What is the all time high TTM EBIT for POINT Biopharma Global?
POINT Biopharma Global all-time high TTM earnings before interest & taxes is $125.52 M
What is POINT Biopharma Global TTM EBIT year-on-year change?
Over the past year, PNT TTM earnings before interest & taxes has changed by +$187.78 M (+234.70%)